1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
